Clincosm LogoSign in Get a demo

Chronic Lymphocytic Leukemia (CLL)

Showing 26 - 50 of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL) Trial (Venetoclax, Rituximab, Ibrutinib)

Not yet recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • (no location specified)
Apr 2, 2022

Chronic Lymphocytic Leukemia (CLL), Relapsed, Refractory Trial in New York (EGFRt/19-28z/4-1BBL CAR T cells)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +2 more
  • EGFRt/19-28z/4-1BBL CAR T cells
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 1, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Zanubrutinib)

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
  • +2 more
Mar 16, 2022

Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Acute Myeloid Leukemia (AML) Trial (Venetoclax)

Available
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • (no location specified)
Mar 28, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Venetoclax monotherapy, Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Venetoclax monotherapy
  • Venetoclax with anti CD20 monoclonal antibody
  • Basking Ridge, New Jersey
  • +9 more
Mar 15, 2022

Small Lymphocytic Leukemia (SLL), Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI (Duvelisib, Ibrutinib)

Terminated
Has Results
  • Small Lymphocytic Leukemia (SLL)
  • Chronic Lymphocytic Leukemia (CLL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 15, 2022

Chronic Lymphocytic Leukemia (CLL) Trial in Worldwide (Venetoclax)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • La Plata, Buenos Aires, Argentina
  • +32 more
Feb 10, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in Rochester (Acalabrutinib, Rituximab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Rochester, New York
    University of Rochester
Feb 7, 2022

Safety and Tolerability, Compare SHINGRIX Vaccine Response Rates, Chronic Lymphocytic Leukemia (CLL) Trial run by the NHLBI

Active, not recruiting
Has Results
  • Safety and Tolerability
  • +3 more
  • Zoster Vaccine Recombinant, Adjuvanted
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 10, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma (FL) Trial in Switzerland, United

Recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • +6 more
  • Tucson, Arizona
  • +23 more
Dec 14, 2021

Oral Venetoclax Tablets in Combination With Intravenous

Terminated
  • Chronic Lymphocytic Leukemia (CLL)
    • Moscow, Moskva, Russian Federation
    • +3 more
    Nov 18, 2021

    Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL) Trial in Japan (azacitadine, venetoclax,

    Completed
    • Non-Hodgkin Lymphoma (NHL)
    • +4 more
    • Nagoya shi, Aichi, Japan
    • +13 more
    Jul 29, 2021

    Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome Trial in Morgantown (umbilical

    Completed
    Has Results
    • Chronic Myelogenous Leukemia (CML)
    • +8 more
    • umbilical cord blood (UCB)
    • Morgantown, West Virginia
      West Virginia University Hospitals Mary Babb Randolph Cancer Cen
    Jun 7, 2021

    Chronic Lymphocytic Leukemia (CLL) Trial in Chicago (Oncoquest-CLL vaccine)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia (CLL)
    • Oncoquest-CLL vaccine
    • Chicago, Illinois
      Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
    Apr 7, 2021

    CD5+ Relapsed/Refractory Hematopoietic Malignancies, Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL) Trial

    Not yet recruiting
    • CD5+ Relapsed/Refractory Hematopoietic Malignancies
    • +5 more
    • CT125A cells
    • Cyclophosphamide, fludarabine
    • (no location specified)
    Feb 19, 2021

    Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

    Completed
    • Myelodysplastic Syndrome (MDS)
    • +6 more
    • Gainesville, Florida
    • +10 more
    Nov 30, 2020

    Chronic Lymphocytic Leukemia (CLL) Trial in Columbus, Salt Lake City (Idelalisib, BI 836826)

    Terminated
    Has Results
    • Chronic Lymphocytic Leukemia (CLL)
    • Columbus, Ohio
    • +1 more
    Nov 23, 2020

    Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF), Chronic Lymphocytic Leukemia (CLL) Trial in United States (Cobomarsen)

    Completed
    • Cutaneous T-cell Lymphoma (CTCL)
    • +4 more
    • Duarte, California
    • +18 more
    Nov 19, 2020

    Non-Hodgkin's Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) Trial

    Completed
    • Non-Hodgkin's Lymphoma (NHL)
    • +2 more
      • (no location specified)
      May 14, 2020

      Chronic Lymphocytic Leukemia (CLL) Trial in Sparta (High phenolic EVOO intake, No High phenolic EVOO intake)

      Completed
      • Chronic Lymphocytic Leukemia (CLL)
      • High phenolic EVOO intake
      • No High phenolic EVOO intake
      • Sparta, Lakonias, Greece
        University of Peloponnese, School of Health Sciences, Department
      Dec 28, 2019

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial (Bendamustine and Rituximab Induction followed by

      Withdrawn
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • Bendamustine and Rituximab Induction followed by Rituximab and Lenalidomide Maintenance
      • (no location specified)
      Nov 13, 2019

      Chronic Lymphocytic Leukemia (CLL) Trial in Toronto (Ofatumumab with GSK2110183)

      Completed
      Has Results
      • Chronic Lymphocytic Leukemia (CLL)
      • Ofatumumab with GSK2110183
      • Toronto, Ontario, Canada
        University Health Network-Princess Margaret Hospital
      Sep 20, 2019

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), B-Cell Non-Hodgkin Lymphomas(NHL) Trial in Nanjing,

      Unknown status
      • Chronic Lymphocytic Leukemia (CLL)
      • +2 more
      • Nanjing, Jiangsu, China
      • +1 more
      Apr 27, 2019

      Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Idelalisib, Rituximab)

      Terminated
      Has Results
      • Chronic Lymphocytic Leukemia (CLL)
      • Small Lymphocytic Lymphoma (SLL)
      • La Jolla, California
      • +5 more
      Oct 19, 2018